How to Get Wegovy Online Legally: Telehealth, Eligibility, and Cost

The short answer

To be a candidate under the drug's FDA label, you generally need a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher together with at least one weight-related condition such as high blood pressure, type 2 diabetes, or abnormal cholesterol. A prescriber confirms this and reviews your full history before writing anything. No legitimate service skips the clinical evaluation.

This page explains the legal telehealth path step by step, how eligibility is decided, how Wegovy's cost actually works (list price versus insurance copay versus the manufacturer savings program versus cash self-pay versus compounded versions), and the concrete warning signs of counterfeit or unapproved sellers. It does not sell or prescribe anything; it helps you understand the route and compare licensed providers in your state.

What Wegovy is, and what it is approved for

Wegovy is the brand name for semaglutide dosed at 2.4 mg, a once-weekly injectable in the GLP-1 receptor agonist class. According to its FDA prescribing information, it is approved for chronic weight management in adults and in adolescents aged 12 and older who meet weight criteria, used alongside a reduced-calorie diet and increased physical activity. That approved use is what makes an online prescription for weight loss legitimate rather than off-label.

This matters because several similar drugs are often discussed interchangeably but are approved for different things. Ozempic is also semaglutide, but its FDA approval is for type 2 diabetes, so prescribing Ozempic purely for weight loss is off-label. Zepbound (tirzepatide) is FDA-approved for chronic weight management, while Mounjaro (also tirzepatide) is approved for type 2 diabetes. When you seek Wegovy specifically, you are asking for the semaglutide product the FDA cleared for weight management.

You can confirm any of this yourself. The FDA's Drugs@FDA database lists every approved product and its approval status, and the manufacturer's prescribing information states the exact indication. If a website describes a product in ways that do not match these authoritative sources, treat that as a warning sign rather than a selling point.

Who is eligible under the FDA label

Wegovy's FDA label sets specific body-mass-index thresholds in its Indications section. An adult generally qualifies with a BMI of 30 or higher, which is the clinical definition of obesity. An adult also qualifies with a BMI of 27 or higher, which is the overweight range, if they also have at least one weight-related comorbid condition. The label names examples such as hypertension, type 2 diabetes, and dyslipidemia (abnormal cholesterol or triglycerides).

BMI is only the entry criterion, not the whole decision. A prescriber also reviews your personal and family medical history, current medications, and contraindications before deciding whether Wegovy is appropriate. The semaglutide label carries a boxed warning about a risk of thyroid C-cell tumors seen in rodent studies, and it is not for people with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2. This is exactly the kind of screening a legitimate telehealth evaluation performs and an illegal seller skips.

For women specifically, one detail is worth raising with a prescriber: semaglutide does not carry a warning about reduced oral contraceptive effectiveness, whereas tirzepatide (Zepbound and Mounjaro) does. If birth control interactions are part of your decision between medications, that difference is a concrete, label-based reason to discuss Wegovy versus a tirzepatide product with your clinician.

The legal telehealth path, step by step

The lawful way to get Wegovy online follows the same medical logic as an in-person visit, just delivered remotely. First, you complete a medical intake: height, weight, medical history, current medications, and your goals. Accurate answers matter, because the prescriber relies on them and because misrepresenting your health to obtain a prescription is both unsafe and can invalidate the care.

Second, a clinician licensed in your state reviews your intake. Depending on the platform and state rules, this may be an asynchronous review or a live video or phone visit. The prescriber determines whether you meet the eligibility criteria, whether Wegovy is safe for you, and whether any other evaluation is needed first. A legitimate service can and sometimes will decline to prescribe; that is a sign the evaluation is real.

Third, if Wegovy is appropriate, the prescription goes to a licensed pharmacy. That may be a mail-order pharmacy that ships to you or a retail pharmacy you choose for pickup. The product you receive should be a genuine, FDA-approved Wegovy pen with proper labeling. Fourth, ongoing care follows: dose titration over several weeks, side-effect monitoring, and refills. Wegovy is titrated gradually rather than started at the full dose, and a real clinical relationship supports that schedule.

How Wegovy's cost actually works

There is no single Wegovy price, which is why generic dollar quotes online are unreliable. What you pay depends on which of several distinct paths applies to you, and the only authoritative live figures come from Novo Nordisk's own pages: NovoCare's Wegovy cost and coverage page and the official Save on Wegovy page. Those pages carry the current list price, the savings-card terms, and self-pay options, and those numbers change over time.

The paths break down like this. The manufacturer list price is the sticker figure before any insurance or discount; almost no one with coverage pays it directly. An insured copay is what your specific plan charges after it applies its formulary rules, prior authorization, and any deductible, and it varies widely between plans, so your own benefits document or NovoCare's coverage tool is the real answer. The Novo Nordisk savings card can lower out-of-pocket cost for eligible commercially insured patients, subject to eligibility and program terms on the savings page.

Then there is cash self-pay, for people without coverage or whose plan excludes weight-loss drugs, and Novo Nordisk has offered self-pay access programs whose current terms live on its own pages. Finally there is compounded semaglutide, which is a different category entirely and is discussed below. Because each path yields a different number, the honest move is to check your insurance benefits and the manufacturer pages for the figure that applies to you rather than trusting a blanket price.

Comparison: the five ways to pay for Wegovy

The table below compares the cost paths structurally so you know which question to ask, not to quote a number that will be out of date by the time you read it. For any live dollar figure, go to NovoCare's Wegovy cost and coverage page or the official Save on Wegovy page.

Reading it top to bottom roughly follows most people's decision: check insurance first, then the savings card if you are commercially insured, then manufacturer self-pay if you are not, and treat compounded products as a separate, non-FDA-approved category with its own risks.

Insurance and prior authorization: what to expect

Whether your plan covers Wegovy is the single biggest factor in what you pay, and coverage for weight-management drugs is inconsistent across employers and plans. Some commercial plans cover it with a copay, some require prior authorization documenting your BMI and related conditions, and some exclude anti-obesity medications entirely. Medicare and Medicaid coverage rules differ again and have their own restrictions. The only way to know your situation is to read your plan's drug formulary or use NovoCare's coverage lookup.

Prior authorization is common. It typically requires your prescriber to submit documentation that you meet the label criteria, sometimes including a record of prior weight-management efforts. This is a normal insurance step, not a reason to bypass the system through an unapproved seller. A good telehealth service will help handle the prior-authorization paperwork rather than steering you toward a product that avoids insurance because it avoids the FDA.

If your plan excludes weight-loss medication, that does not mean your only option is a sketchy website. It means your realistic choices are the manufacturer's self-pay pathway, an appeal or exception request through your plan, or a conversation with your clinician about FDA-approved alternatives. Each of those keeps you inside the legal, verifiable supply chain.

NovoCare and manufacturer savings programs

NovoCare is Novo Nordisk's own patient-support resource for its products, including Wegovy. Its Wegovy cost and coverage page is the authoritative place to check current pricing structure, understand coverage, and find the manufacturer's savings and self-pay offerings. Because it is run by the drug's maker, the figures and program terms there are current in a way that third-party price lists are not.

The Save on Wegovy page hosts the manufacturer savings card and its eligibility rules. Savings cards generally apply to people with commercial insurance and carry conditions and dollar caps, and government-insured patients are usually excluded from copay cards by law. Read the eligibility terms directly rather than assuming you qualify, and note that these programs can change.

The practical takeaway: before you judge Wegovy as unaffordable, check both your insurance benefits and these manufacturer pages. The gap between the list price and what an eligible, insured patient actually pays with a savings card can be large, and none of it requires stepping outside the legitimate pharmacy system.

Compounded semaglutide: what the FDA has warned

Compounded semaglutide is not the same thing as Wegovy, and this is one of the most important distinctions on this page. Compounded drugs are mixed by pharmacies and are not FDA-approved products; they do not go through the FDA review for safety, effectiveness, and manufacturing quality that the branded product does. The FDA has issued warnings about unapproved and compounded GLP-1 products, including concerns about dosing errors and unverified ingredients.

Compounding of these drugs expanded during periods when the branded products were in shortage, because federal rules allow certain compounding when an FDA-approved drug is on the shortage list. As shortage status changes, so does the legal basis for compounding, which means a compounded product that was widely marketed at one point may be on different legal footing later. That shifting landscape is one more reason to treat compounded semaglutide as a distinct, higher-risk category rather than a cheaper version of Wegovy.

If cost is driving you toward a compounded product, the safer sequence is to first exhaust the legitimate options: check insurance, the savings card, and the manufacturer self-pay program, and discuss FDA-approved alternatives with your clinician. If you still consider a compounded product, do it only through a licensed prescriber and a licensed pharmacy that can tell you exactly what you are receiving, and verify claims against the FDA's Drugs@FDA database.

How to tell a legitimate provider from an illegal one

A legitimate online provider has a few non-negotiable features. It requires a prescription written by a clinician licensed in your state after an actual medical evaluation. It dispenses through a licensed U.S. pharmacy. It gives you a real product with proper FDA labeling and a pharmacist you can reach with questions. And it is willing to say no if you are not an appropriate candidate.

An illegal or dangerous seller shows the opposite pattern. It offers to ship Wegovy or semaglutide with no prescription and no meaningful health screening. It sells vials of research chemicals or unlabeled products, sometimes marketed as not for human use to dodge regulation. It pressures you with urgency, deep discounts, or bulk deals, takes payment by wire or cryptocurrency, and provides no licensed pharmacist or verifiable pharmacy. Any one of these is enough reason to walk away.

You can verify independently. State pharmacy boards license pharmacies, and the FDA's Drugs@FDA database confirms whether a product is an approved drug. If a seller cannot be squared with those authoritative checks, no price is low enough to justify the risk of a counterfeit or contaminated injectable.

Wegovy versus other GLP-1 options for weight

If your goal is FDA-approved chronic weight management, the two branded injectables cleared for that use are Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide). Both are prescription-only and both follow the same legal telehealth-plus-licensed-pharmacy path. Ozempic and Mounjaro contain the same active ingredients as Wegovy and Zepbound respectively, but their FDA approvals are for type 2 diabetes, so using them for weight alone is off-label.

For women weighing these options, a label-based difference is worth naming. Tirzepatide products (Zepbound and Mounjaro) carry a warning that they can reduce the effectiveness of oral contraceptives, and their labeling advises additional contraception measures around starting and dose changes. Semaglutide (Wegovy, Ozempic) does not carry that warning. If reliable birth control is part of your planning, that is a concrete reason to discuss Wegovy specifically with your prescriber.

The NIDDK, part of the NIH, publishes an overview of prescription medications for overweight and obesity that describes how this drug class works and where it fits alongside diet and activity. It is a useful, non-commercial reference for understanding the category before your telehealth visit, and it reinforces that these medications are tools used with lifestyle change, not standalone fixes.

What to do next

The realistic sequence is: confirm you meet the label criteria on paper (BMI of 30 or more, or 27 or more with a weight-related condition), check your insurance formulary and NovoCare to understand your likely cost, and then start a telehealth evaluation with a clinician licensed in your state who can prescribe Wegovy through a licensed pharmacy. Keep the manufacturer's savings and self-pay pages open so you are working from current numbers, not a stale quote.

Throughout, keep the two hard lines in view. Never accept a product without a prescription and a licensed pharmacy behind it, and treat compounded semaglutide as a separate, non-FDA-approved category with its own risks rather than as a discount Wegovy. Every safe path runs through a licensed prescriber and a licensed pharmacy.

This site does not sell or prescribe medication and is not a substitute for medical advice. Use it to understand the legal route and to compare providers licensed in your state, then let a qualified clinician make the prescribing decision with your full medical history in front of them.

Frequently asked questions

Can I get Wegovy online without a prescription?

No. Wegovy is a prescription-only FDA-approved drug. The legal online path requires a medical evaluation by a clinician licensed in your state, and the drug must be dispensed by a licensed U.S. pharmacy. Any website offering to ship it with no prescription is operating illegally and may be selling counterfeit or unapproved product.

What BMI do I need to qualify for Wegovy?

Wegovy's FDA label sets eligibility at a BMI of 30 or higher, or a BMI of 27 or higher together with at least one weight-related condition such as hypertension, type 2 diabetes, or abnormal cholesterol. BMI is the entry criterion; a prescriber also reviews your full medical history before deciding whether it is appropriate.

How much does Wegovy cost online?

There is no single price. What you pay depends on your path: manufacturer list price, insured copay, the Novo Nordisk savings card, cash self-pay, or a non-FDA-approved compounded version. For a current figure that applies to you, check your insurance formulary and Novo Nordisk's own NovoCare and Save on Wegovy pages, since prices change.

Is Wegovy the same as Ozempic?

Both contain semaglutide, but they are approved for different uses. Wegovy (semaglutide 2.4 mg) is FDA-approved for chronic weight management. Ozempic is FDA-approved for type 2 diabetes, so using Ozempic for weight loss alone is off-label. If you want the product cleared for weight management, ask specifically about Wegovy.

Is compounded semaglutide a safe way to save money?

Compounded semaglutide is not an FDA-approved product and does not go through the FDA's review for safety, effectiveness, and manufacturing quality. The FDA has warned about unapproved and compounded GLP-1 products. Before considering it, exhaust the legitimate options (insurance, savings card, manufacturer self-pay) and only proceed through a licensed prescriber and licensed pharmacy.

Does Wegovy affect birth control?

Semaglutide, the active ingredient in Wegovy, does not carry a warning about reduced oral contraceptive effectiveness. Tirzepatide products (Zepbound and Mounjaro) do carry that warning. If reliable contraception is part of your decision, this label-based difference is worth discussing with your prescriber.

How do I know an online pharmacy is legitimate?

A legitimate provider requires a prescription from a state-licensed clinician, dispenses through a licensed U.S. pharmacy, delivers an FDA-approved product with proper labeling, and gives you access to a pharmacist. Warning signs include no prescription required, unlabeled vials, urgency or bulk deals, and payment by wire or cryptocurrency. Verify products against the FDA's Drugs@FDA database.

Will my insurance cover Wegovy?

It varies. Some commercial plans cover Wegovy with a copay, often after prior authorization documenting your BMI and related conditions; some exclude weight-loss drugs entirely; Medicare and Medicaid have their own rules. Check your plan's drug formulary or use NovoCare's coverage tool to confirm before assuming a cost.

Primary sources

1. FDA Prescribing Information, Wegovy (semaglutide) injection.
2. NovoCare, Wegovy cost & coverage.
3. Novo Nordisk, Save on Wegovy.
4. FDA Prescribing Information, Zepbound (tirzepatide) injection.
5. FDA Prescribing Information, Ozempic (semaglutide) injection.
6. FDA Drugs@FDA approved-drug database (verify a product is FDA-approved).
7. NIDDK (NIH), Prescription Medications to Treat Overweight & Obesity.